https://www.selleckchem.com/pr....oducts/rimiducid-ap1
This facet is beginning to be thoroughly addressed by the organ-on-a-chip community, but holds enormous potential in the development of novel diabetes therapeutics. Furthermore, high throughput strategies focused on studying β-cell biology, improving β-cell differentiation, or proliferation have led to enormous contributions in the field and will no doubt be instrumental in bringing new diabetes therapeutics to the clinic. The study aimed to establish the views of a range of stakeholders about their experiences of the newly imp
Like
Comment
Share
